HanchorBio Inc. (TPE:7827)
Taiwan · Delayed Price · Currency is TWD 156.50
+0.50 (0.32%)
At close: Aug 6, 2026
HanchorBio Market Cap
HanchorBio has a market cap or net worth of 20.38 billion as of August 7, 2026. Its market cap has increased by 108.87% in one year.
Market Cap
20.38B
Enterprise Value
19.81B
Revenue
312.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
156.50
ChartMarket Cap Chart
Since June 20, 2025, HanchorBio's market cap has increased from 5.52B to 20.38B, an increase of 269.15%. That is a compound annual growth rate of 217.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 20.31B | 76.43% |
| Dec 31, 2025 | 11.51B | 108.56% |
| Jun 20, 2025 | 5.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TLC BioSciences | 28.05B |
| Elixiron Immunotherapeutics (Cayman) Limited | 10.94B |
| Intelligene | 6.82B |
| Uwell Biopharma | 6.75B |
| Tripartite Therapeutics | 5.29B |
| Obigen Pharma | 3.84B |
| Pet Pharm Biotech | 2.77B |
| BIONET Therapeutics | 2.10B |